Serial magnetization transfer imaging to characterize the early evolution of new MS lesions

Neurology

Volumn 51, Issue 3, 1998, Pages 758-764

  Silver, N C ^a   Lai, M ^a   Symms, M R ^a   Barker, G J ^a   McDonald, W I ^a   Miller, D H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; CASE REPORT; DEMYELINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENE DISRUPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE INTENSIFIER; MAGNETISM; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

EID: 0031783393     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.3.758     Document Type: Article

References (46)

1. Dawson JW. The history of disseminated sclerosis. Trans R Soc Edinburgh 1916;50:517-740.
2. Prineas JW, McDonald WI. Demyelinating diseases. In: Graham DI, Lantos PL, eds. Greenfield's neuropathology. London: Arnold, 1997:815-868.
3. Young IR, Hall AS, Pallis CA, Legg NJ, Bydder GM, Steiner RE. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 1981;2:1063-1066.
4. Miller DH. Magnetic resonance in monitoring the treatment of multiple sclerosis. Ann Neurol 1994;36:S91-S94.
5. Dousset V, Brochet B, Vital A, et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. Am J Neuroradiol 1995;16:225-231.
6. Dousset V, Brochet B, Vital F, Nagem J, Bonnet, Caillé JM. MR imaging including diffusion and magnetization transfer of chronic relapsing experimental encephalomyelitis - correlation with immunological and pathological datas. Proc Soc Magn Reson 1994;1401. Abstract.
7. Dousset V, Armand JP, Degreze P, Mieze S, Lafon P, Caillé JM. Progressive multifocal leucoencephalopathy studied by magnetization transfer imaging. Proc Soc Magn Reson Eur Soc Magn Reson Med Biol 1995;284. Abstract.
8. Silver NC, Barker GJ, MacManus DG, Miller DH, Thorpe JW, Howard RS. Decreased magnetisation transfer ratio due to demyelination: a case of central pontine myelinolysis. J Neurol Neurosurg Psychiatry 1996;61:208-209.
9. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterisation with magnetization transfer imaging. Radiology 1992;182:483-491.
10. Thorpe JW, Barker GJ, MacManus DG, et al. Magnetization transfer ratio and transverse magnetization decay analysis of the optic nerves in optic neuritis. Proc Soc Magn Reson 1994; 883. Abstract.
11. Lexa FJ, Grossman RI, Rosenquist AC. MR of Wallerian degeneration in the feline visual system: characterization by magnetization transfer rate with histopathologic correlation. AJNR Am J Neuroradiol 1994;15:201-212.
12. Kimura H, Meaney DF, McGowan JC, et al. Magnetization transfer imaging of diffuse axonal injury following experimental brain injury in the pig: characterization by magnetization transfer ratio with histopathologic correlation. J Comput Assist Tomogr 1996;20:540-546.
13. Hanover DA, Kimura H, Yang JH, Grossman RI, Smith DH, McGowan JC. Sensitivity of magnetization transfer imaging to diffuse axonal injury at multiple time points. Proc ISMRM 1997:624. Abstract.
14. Hawkins CP, Munro PMG, Mackenzie F, et al. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain 1990;113:365-378.
15. Kermode AG, Thompson AJ, Tofts P, et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain 1990;113:1477-1489.
16. Katz D, Taubenberger JK, Cannella B, McFarlin D, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993;34:661-669.
17. Thompson AJ, Kermode AG, Wicks D, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991;29:53-62.
18. Thompson AJ, Miller DH, Youl B, et al. Serial gadolinium-enhanced MRI in relapsing-remitting multiple sclerosis of varying disease duration. Neurology 1992;42:60-63.
19. Gonzalez-Scarano F, Grossman RI, Galetta S, Atlas SW, Silberberg DH. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging. Ann Neurol 1987;21:300-306.
20. Smith ME, Stone LA, Albert PS, et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 1993;33:480-489.
21. Frank JA, Stone LA, Smith ME, Albert PS, Maloni H, McFarland HF. Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: implications for treatment trials. Ann Neurol 1994; 36:S86-S90.
22. Poser CM, Paty D, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
23. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
24. Lai M, Hodgson T, Gawne-Cain M, et al. A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;60:339-341.
25. Gallagher HL, MacManus DG, Webb SL, Miller DH. A reproducible repositioning method for serial magnetic resonance imaging studies of the brain in treatment trials for multiple sclerosis. J Magn Reson Imaging 1997;7:439-441.
26. Barker GJ, Tofts PS, Gass A. An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio. Magn Reson Imaging 1996;14:403-411.
27. Plummer DL. Displmage: a display and analysis tool for medical images. Revista Di Neuroloradiologica 1992;5:489-495.
28. Symms MR, Barker GJ, Wang L, Tofts PS. Improving spatial registration of multislice two dimensional MR images with a radiographical repositioning technique. Proc Int Soc Magn Reson Med 1997:689. Abstract.
29. Woods RP, Cherry SR, Mazziotta JC. Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr 1992;16:620-633.
30. Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 1991;180:467-474.
31. Hiehle JF, Grossman RI, Ramer KN, Gonzalez-Scarano F, Cohen JA. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. AJNR Am J Neuroradiol 1995;16:69-77.
32. Campi A, Filippi M, Comi G, Scotti G, Gerevini S, Dousset V. Magnetization transfer ratios of contrast-enhancing and nonenhancing lesions in multiple sclerosis. Neuroradiology 1996; 38:115-119.
33. Petrella JR, Grossman RI, McGowan JC, Campbell G, Cohen JA. Multiple sclerosis lesions: relationship between MR enhancement pattern and magnetization transfer effect. AJNR Am J Neuroradiol 1996;17:1041-1049.
34. Lai HM, Davie CA, Gass A, et al. Serial magnetization transfer ratios in gadolinium-enhancing lesions in multiple sclerosis. J Neurol 1997;244:308-311.
35. Alonso J, Rovira A, Gucurella MG, et al. Serial magnetization transfer imaging in multiple sclerosis lesions. Proc ISMRM 1997:639. Abstract.
36. McDonald WI, Miller DH, Barnes D. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 1992; 18:319-334.
37. Calder V, Owen S, Watson C, Feldmann M, Davison A. MS: a localized immune disease of the central nervous system. Immunol Today 1989;10:99-103.
38. Seitz RJ, Reiners K, Himmelmann F, Heininger K, Hartung HP, Toyka KV. The blood-nerve barrier in Wallerian degeneration: a sequential long-term study. Muscle Nerve 1989;12: 627-635.
39. Latker CH, Wadhwani KC, Balbo A, Rapoport SI. Blood-nerve barrier in the frog during Wallerian degeneration: are axons necessary for maintenance of barrier function? J Comp Neurol 1991;308:650-664.
40. Bakker DA, Ludwin SK. Blood-brain barrier permeability during Cuprizone-induced demyelination. Implications for pathogenesis of immune-mediated demyelinating diseases. J Neurol Sci 1987;78:125-137.
41. Lightman S, McDonald WI, Bird AC, et al. Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain 1987;110:405-414.
42. Narayana PA, Doyle TJ, Lai D, Wolinsky JS. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 1998;43:56-71.
43. Lassmann H, Suchanek G, Ozawa K. Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann Neurol 1994;36:S42-S46.
44. Barnes D, Munro PMG, Youl BD, Prineas JW, McDonald WI. The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain 1991;114:1271-1280.
45. Mehta RC, Pike GB, Enzmann DR. Measure of magnetization transfer in multiple sclerosis demyelinating plaques, white matter ischemic lesions, and edema. AJNR Am J Neuroradiol 1996;17:1051-1055.
46. Prineas JW, Connell F. Remyelination in multiple sclerosis. Ann Neurol 1979;5:22-31.